Pre-treatment | Post-treatment | p-value | |
---|---|---|---|
CD4+ cells (%) | 46.9 | 40.1 | 0.045 |
% of CD4+ cells | |||
IFN-γ + | 20.0 | 23.9 | 0.225 |
Foxp3+ | 7.7 | 9.2 | 0.047 |
CD8+ cells (%) | 25.6 | 30.1 | 0.043 |
% of CD8+ cells | |||
IFN-γ + | 58.0 | 62.2 | 0.108 |
Granz B+ | 46.7 | 55.5 | 0.101 |
% of CD8+CD4−CD3+ cells | |||
CD8dimCD3+ | 10.4 | 12.2 | 0.015 |
CD8dimCD3− | 27.4 | 28.7 | 0.709 |
CD8hiCD3+ | 61.6 | 59.1 | 0.454 |
% of CD8dimCD3+ cells | |||
IFN-γ+ | 60.7 | 62.9 | 0.404 |
Granzyme B+ | 34.7 | 42.6 | 0.023 |
% of CD8dimCD3− cells | |||
IFN-γ+ | 70.5 | 68.9 | 0.572 |
Granzyme B+ | 91.2 | 91.5 | 0.853 |
% of CD8hiCD3+ cells | |||
IFN-γ+ | 51.1 | 57.3 | 0.054 |
Granzyme B+ | 26.4 | 36.7 | 0.009 |